{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:15:58Z","timestamp":1774005358611,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["CRADA 2299"],"award-info":[{"award-number":["CRADA 2299"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN26120150003I"],"award-info":[{"award-number":["HHSN26120150003I"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.isci.2025.114238","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:23:15Z","timestamp":1764202995000},"page":"114238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human disease"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-0604","authenticated-orcid":false,"given":"Ludmila","family":"Szabova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie B.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa M.","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bassel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah B.","family":"Householder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margalie","family":"Edouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Ries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serguei","family":"Kozlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Keith","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendi","family":"Custer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goli","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-2504","authenticated-orcid":false,"given":"Zoe","family":"Weaver Ohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.114238_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2025.114238_bib2","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2025.114238_bib3","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2025.114238_bib4","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.2147\/OTT.S321658","article-title":"Clinical Application of Tumor Vascular Disrupting Therapy: A Systematic Review and Meta-Analysis","volume":"14","author":"Tsang","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.isci.2025.114238_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11523-023-00970-w","article-title":"PARP Inhibitors in Ovarian Cancer: A Review","volume":"18","author":"O'Malley","year":"2023","journal-title":"Target. Oncol."},{"key":"10.1016\/j.isci.2025.114238_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00018-022-04395-y","article-title":"Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application","volume":"79","author":"Ciucci","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2025.114238_bib7","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114238_bib8","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1210\/en.2014-1977","article-title":"The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice","volume":"156","author":"Kim","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2025.114238_bib9","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/j.celrep.2019.10.122","article-title":"A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development","volume":"29","author":"Lawrenson","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.114238_bib10","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-11-3834","article-title":"Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer","volume":"72","author":"Szabova","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.114238_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.114238_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.4783","article-title":"Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse","volume":"240","author":"Wu","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2025.114238_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4927","article-title":"High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease","volume":"243","author":"Zhai","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2025.114238_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.114238_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymeth.2021.02.003","article-title":"Verification of CRISPR editing and finding transgenic inserts by Xdrop indirect sequence capture followed by short- and long-read sequencing","volume":"191","author":"Blondal","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.isci.2025.114238_bib16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nm.1865","article-title":"An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice","volume":"14","author":"Traykova-Brauch","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.114238_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080459","article-title":"Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.114238_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114238_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2025.114238_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.114238_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095649","article-title":"Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer","volume":"9","author":"Szabova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.114238_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.22.01549","article-title":"Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1\/GOG 3004 Trial","volume":"41","author":"DiSilvestro","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.114238_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"Olive","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.114238_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-19-2558","article-title":"Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts","volume":"80","author":"McCool","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.114238_bib25","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1158\/1078-0432.CCR-19-0419","article-title":"The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib","volume":"25","author":"Marzi","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.114238_bib26","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1200\/JCO.2009.27.5719","article-title":"Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer","volume":"28","author":"Konstantinopoulos","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.114238_bib27","first-page":"517","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.114238_bib28","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.114238_bib29","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1158\/1078-0432.CCR-16-2196","article-title":"Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes","volume":"23","author":"Kommoss","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.114238_bib30","first-page":"3459","article-title":"Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium","volume":"63","author":"Flesken-Nikitin","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.114238_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108978","article-title":"Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube","volume":"35","author":"Dinh","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.114238_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105861","article-title":"Distinct niche structures and intrinsic programs of fallopian tube and ovarian surface epithelial cells","volume":"26","author":"Qin","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.isci.2025.114238_bib33","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1038\/s41467-024-52984-1","article-title":"Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma","volume":"15","author":"Flesken-Nikitin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114238_bib34","first-page":"3031","article-title":"In vivo genetic cell lineage tracing reveals that oviductal secretory cells self-renew and give rise to ciliated cells","volume":"144","author":"Ghosh","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.isci.2025.114238_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju249","article-title":"Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer","volume":"106","author":"Konecny","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.isci.2025.114238_bib36","author":"Leek JT"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422502499X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422502499X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:07:41Z","timestamp":1773997661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258900422502499X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S258900422502499X"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.114238","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human disease","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.114238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114238"}}